HER2-directed dendritic cell vaccine (DC1)

· H. Lee Moffitt Cancer Center and Research Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HER2-directed dendritic cell vaccine (DC1), covering 2026-03-02 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab [Phase 2]